Daniel Char

Daniel Char is an accomplished legal executive with extensive experience in corporate governance and strategic counsel. Currently serving as Chief Legal Officer at Oculis since September 2024, Daniel collaborates with the executive leadership team on enterprise-wide strategy and business matters. Previously, Daniel held positions as Senior Vice President, Chief Legal Officer, and Corporate Secretary at ImmunoGen, Inc. from November 2022 to May 2024, and General Counsel & Corporate Secretary at Evelo Biosciences from January 2018 to November 2022. Earlier career highlights include Associate General Counsel - Commercial at Smith & Nephew and Vice President, General Counsel & Corporate Secretary at Targanta Therapeutics Corporation. Daniel earned a Juris Doctor from Harvard Law School and a Bachelor of Arts in Economics from Tufts University.